{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-249270","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.649947+00:00","generated_at":"2026-05-30T06:48:55.028736+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Plus Therapeutics receives Nasdaq extension until March 4, 2025 to regain minimum equity compliance","bullets":["Nasdaq Hearings Panel granted extension to March 4, 2025 for Plus Therapeutics to meet $2.5M stockholders' equity minimum.","Company has been non-compliant since March 8, 2024; hearing was held on October 22, 2024.","No assurance of regaining compliance; delisting risk remains if equity condition not met by deadline.","Stock continues trading on Nasdaq Capital Market under ticker PSTV during extension period."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-249270","json":"https://secwatch.observer/filing/0001193125-24-249270.json","markdown":"https://secwatch.observer/filing/0001193125-24-249270.md","text":"https://secwatch.observer/filing/0001193125-24-249270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524249270/0001193125-24-249270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524249270/d860547d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:48:55.028736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}